COSMOS Pharmaceutical Corporation (TYO:3349)
Japan
· Delayed Price · Currency is JPY 7,414.00
-83.00 (-1.11%)
At close: Dec 5, 2025
COSMOS Pharmaceutical Revenue
COSMOS Pharmaceutical had revenue of 272.39B JPY in the quarter ending August 31, 2025, with 4.03% growth. This brings the company's revenue in the last twelve months to 1.02T, up 3.73% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.
Revenue (ttm)
1,021.94B
Revenue Growth
+3.73%
P/S Ratio
0.58
Revenue / Employee
179.01M
Employees
5,709
Market Cap
587.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 1,011.39B | 46.40B | 4.81% |
| May 31, 2024 | 964.99B | 137.29B | 16.59% |
| May 31, 2023 | 827.70B | 72.28B | 9.57% |
| May 31, 2022 | 755.41B | 28.99B | 3.99% |
| May 31, 2021 | 726.42B | 42.02B | 6.14% |
| May 31, 2020 | Pro | Pro | Pro |
| May 31, 2019 | Pro | Pro | Pro |
| May 31, 2018 | Pro | Pro | Pro |
| May 31, 2017 | Pro | Pro | Pro |
| May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Terumo | 1,062.42B |
| Astellas Pharma | 2,006.82B |
| Olympus | 977.65B |